144 related articles for article (PubMed ID: 38793589)
21. Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome.
Lulla V; Wandel MP; Bandyra KJ; Ulferts R; Wu M; Dendooven T; Yang X; Doyle N; Oerum S; Beale R; O'Rourke SM; Randow F; Maier HJ; Scott W; Ding Y; Firth AE; Bloznelyte K; Luisi BF
J Virol; 2021 Jun; 95(14):e0066321. PubMed ID: 33963053
[TBL] [Abstract][Full Text] [Related]
22. Construction and characterization of two SARS-CoV-2 minigenome replicon systems.
Zhang H; Fischer DK; Shuda M; Moore PS; Gao SJ; Ambrose Z; Guo H
J Med Virol; 2022 Jun; 94(6):2438-2452. PubMed ID: 35137972
[TBL] [Abstract][Full Text] [Related]
23. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
Zhang L; Richards A; Barrasa MI; Hughes SH; Young RA; Jaenisch R
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 33958444
[TBL] [Abstract][Full Text] [Related]
24. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
Zhang X; Liu Y; Liu J; Bailey AL; Plante KS; Plante JA; Zou J; Xia H; Bopp NE; Aguilar PV; Ren P; Menachery VD; Diamond MS; Weaver SC; Xie X; Shi PY
Cell; 2021 Apr; 184(8):2229-2238.e13. PubMed ID: 33691138
[TBL] [Abstract][Full Text] [Related]
25. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
[TBL] [Abstract][Full Text] [Related]
26. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
[TBL] [Abstract][Full Text] [Related]
27. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
28. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis.
Feng X; Zhang X; Jiang S; Tang Y; Cheng C; Krishna PA; Wang X; Dai J; Zeng J; Xia T; Zhao D
Comput Struct Biotechnol J; 2022; 20():5193-5202. PubMed ID: 36059866
[TBL] [Abstract][Full Text] [Related]
29. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
[TBL] [Abstract][Full Text] [Related]
30. Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin.
Zhang H; Guo H
J Med Virol; 2024 Mar; 96(3):e29547. PubMed ID: 38511574
[TBL] [Abstract][Full Text] [Related]
31. Insertion of foreign genes into the simian varicella virus genome by Tn7-mediated site-specific transposition.
Gray WL
J Virol Methods; 2024 Jun; 327():114936. PubMed ID: 38583808
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.
Williams CG; Jureka AS; Silvas JA; Nicolini AM; Chvatal SA; Carlson-Stevermer J; Oki J; Holden K; Basler CF
Cell Rep; 2021 Aug; 36(5):109479. PubMed ID: 34320401
[TBL] [Abstract][Full Text] [Related]
33. An Infectious cDNA Clone of SARS-CoV-2.
Xie X; Muruato A; Lokugamage KG; Narayanan K; Zhang X; Zou J; Liu J; Schindewolf C; Bopp NE; Aguilar PV; Plante KS; Weaver SC; Makino S; LeDuc JW; Menachery VD; Shi PY
Cell Host Microbe; 2020 May; 27(5):841-848.e3. PubMed ID: 32289263
[TBL] [Abstract][Full Text] [Related]
34. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
35. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
[TBL] [Abstract][Full Text] [Related]
36. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
[TBL] [Abstract][Full Text] [Related]
37. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
38. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
[No Abstract] [Full Text] [Related]
39. A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
Pahmeier F; Neufeldt CJ; Cerikan B; Prasad V; Pape C; Laketa V; Ruggieri A; Bartenschlager R; Cortese M
J Virol; 2021 Jan; 95(4):. PubMed ID: 33257477
[TBL] [Abstract][Full Text] [Related]
40. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
